Trial Profile
The Pharmacokinetic Profile of a Single Dose of Ferriprox in Patients With Sickle Cell Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2022
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Sickle cell anaemia
- Focus Pharmacokinetics
- Sponsors ApoPharma
- 01 Mar 2022 Results published in the Annals of Hematology
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association.
- 11 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.